Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Organon & Co.
(NY:
OGN
)
20.71
-0.04 (-0.19%)
Official Closing Price
Updated: 4:10 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Organon & Co.
< Previous
1
2
3
4
5
6
Next >
Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell
November 11, 2021
Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma.
Via
Investor's Business Daily
Earnings Scheduled For November 11, 2021
November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...
Via
Benzinga
Why Merck's Strong Outlook For 2021 Could Become Even More Bullish
October 28, 2021
Merck issued upbeat guidance for 2021 that could grow if Covid pill molnupiravir gains authorization.
Via
Investor's Business Daily
Europe's Unicorns
October 15, 2021
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit.
Via
Talk Markets
Expert Ratings For Organon
October 07, 2021
Analysts have provided the following ratings for Organon (NYSE:OGN) within th...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Organon
September 01, 2021
Organon (NYSE:OGN) has observed the following analyst ratings within the last...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Unusual Options Activity Insight: UP Fintech Holding
July 30, 2021
Organon (NYSE:OGN) shares experienced unusual options activi...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
Upgrades For State Street Corporation (NYSE:
Via
Benzinga
Top Stocks Warren Buffett Just Bought
August 18, 2021
These were Berkshire Hathaway's biggest buys during Q2, 2021.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
September 01, 2021
Upgrades For Chatham Lodging Trust (NYSE:
Via
Benzinga
Friday the Thirteenth
August 13, 2021
The stock week in points eastward was mixed. The USA markets face a bear correction.
Via
Talk Markets
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
August 17, 2021
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and...
Via
Benzinga
Merck Spinoff Organon Just Reported Its First Quarter — Here's What You Need To Know
August 12, 2021
Organon crushed Wall Street's second-quarter expectations on Thursday and announced its first dividend, leading OGN stock to pop.
Via
Investor's Business Daily
Earnings Scheduled For August 12, 2021
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
ObsEva Stock Surges On Potential $500M Ebopiprant Deal For Preterm Labor
July 27, 2021
Organon & Co (NYSE: OGN) will license the global development, manufacturing, and commercial rights to ObsEva SA's (NASDAQ: OBSV) ebopiprant (OBE022)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
July 23, 2021
Upgrades Craig-Hallum upgraded the previous rating for Lindblad Expeditions Holdings Inc (NAS...
Via
Benzinga
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 22, 2021
July 22, 2021
Upgrades According to Stephens & Co., the prior rating for World Acceptance Corp (NASDAQ:...
Via
Benzinga
Why Ocugen Shares Are Rallying Today
July 15, 2021
Ocugen, Inc. (NASDAQ: OCGN) shares were advancing strongly Thursday after the biopharma issued a regulatory update. Pennsylvania-based Ocugen said it has initiated a rolling...
Via
Benzinga
3 Stocks I'd Avoid at All Costs
July 13, 2021
On the surface, these companies seem like underpriced investments, but look a little closer and there's a good reason to stay away.
Via
The Motley Fool
Stay Away From Low-Growth Organon
July 08, 2021
Organon's low growth, lack of strong catalysts and likely average future dividend combine to make OGN stock unattractive.
Via
InvestorPlace
Summer Friday
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Via
Talk Markets
Don’t Miss the Opportunity Presented by Organon Stock
June 23, 2021
If a company's spun off from a pharmaceutical giant, you'd think the buzz about it would be deafening. Yet OGN stock remains an underappreciated gem.
Via
InvestorPlace
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
Motivation Really Matters When It Comes to Organon
June 17, 2021
Though spun-off entities can perform very well, with OGN stock, you should assess which company is getting the better deal.
Via
InvestorPlace
Continued Uncertainty
June 15, 2021
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.